Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
17 hedge funds and large institutions have $27.4K invested in Coeptis Therapeutics Warrants in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
1.19% less ownership
Funds ownership: 5.67% → 4.47% (-1.2%)
55% less capital invested
Capital invested by funds: $61.3K → $27.4K (-$33.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5 |
| 2 |
Wells Fargo
San Francisco,
California
|
+$4 |
| 3 |
CS
Clear Street
New York
|
+$2 |
| 4 |
CAC
Cowen and Company
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$3.66K |
| 2 |
HF
HRT Financial
New York
|
-$2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$99 |
COEPW Hedge Fund Activity: Q3 2024 in Review
17 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q3 2024, worth a combined $27.4K — down 55% from $61.3K a quarter earlier.
Fund positioning in COEPW was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $5. The largest seller was Meteora Capital, cutting an estimated $3.66K.
- 17 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $27.4K of Coeptis Therapeutics Warrants stock for Q3 2024, down 55% quarter-over-quarter.
- 1 fund opened new Coeptis Therapeutics Warrants positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q3 2024 was Citadel Advisors, an estimated $5 added.
- The largest Coeptis Therapeutics Warrants seller in Q3 2024 was Meteora Capital, an estimated $3.66K sold.
Based on aggregated 13F filings for Q3 2024.